Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Safety, reactogenicity and immunogenicity study of GSK Biologicals’ pneumococcal vaccine GSK1024850A, given either as a booster dose or as a 2-dose catch-up immunization in healthy Nigerian children
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
113199
NCT01153893
Infections, Streptococcal
Phase 3
 
An annotated case report form is not available for this study. A blank case report form will be provided.
June 2014

Powered by ideaPoint, Inc.